348 related articles for article (PubMed ID: 28240787)
21. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).
Essilini A; Comont T; Germain J; Brun N; Dingremont C; Castel B; Arista S; Madaule S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D; Moulis G;
Eur J Haematol; 2018 May; 100(5):412-418. PubMed ID: 29360249
[TBL] [Abstract][Full Text] [Related]
23. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
[TBL] [Abstract][Full Text] [Related]
24. Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding.
Grimaldi D; Canouï-Poitrine F; Croisille L; Lee K; Roudot-Thoraval F; Languille L; Khellaf M; Michel M; Godeau B; Bierling P
Ann Hematol; 2014 Feb; 93(2):309-15. PubMed ID: 23912633
[TBL] [Abstract][Full Text] [Related]
25. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
Tsuda H; Tsuji T; Tsuji M; Yamasaki H
Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
[TBL] [Abstract][Full Text] [Related]
27. Predictors of chronic idiopathic thrombocytopenic purpura.
ElAlfy M; Farid S; Abdel Maksoud A
Pediatr Blood Cancer; 2010 Jul; 54(7):959-62. PubMed ID: 20405514
[TBL] [Abstract][Full Text] [Related]
28. Gender-related analysis of the clinical presentation, treatment response and outcome in patients with immune thrombocytopenia.
Andrès E; Mecili M; Fothergill H; Zimmer J; Vogel T; Maloisel F
Presse Med; 2012 Sep; 41(9 Pt 1):e426-31. PubMed ID: 22459990
[TBL] [Abstract][Full Text] [Related]
29. Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012.
Michel M; Suzan F; Adoue D; Bordessoule D; Marolleau JP; Viallard JF; Godeau B
Br J Haematol; 2015 Jul; 170(2):218-22. PubMed ID: 25824587
[TBL] [Abstract][Full Text] [Related]
30. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
[TBL] [Abstract][Full Text] [Related]
31. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
33. Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.
Moulis G; Rueter M; Duvivier A; Mahévas M; Viallard JF; Comont T; Chèze S; Audia S; Ebbo M; Terriou L; Lega JC; Jeandel PY; Hemim I; Bozzi S; Daak A; Okada H; Bonnotte B; Michel M; Lapeyre-Mestre M; Godeau B;
Br J Haematol; 2024 Apr; 204(4):1476-1482. PubMed ID: 38267268
[TBL] [Abstract][Full Text] [Related]
34. Age and duration of bleeding symptoms at diagnosis best predict resolution of childhood immune thrombocytopenia at 3, 6, and 12 months.
Revel-Vilk S; Yacobovich J; Frank S; Ben-Ami T; Yechieli M; Shkalim V; Lebel A; Semo-Oz R; Tamary H
J Pediatr; 2013 Nov; 163(5):1335-9.e1-2. PubMed ID: 23891349
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea.
Lee JY; Lee JH; Lee H; Kang B; Kim JW; Kim SH; Lee JO; Kim JW; Kim YJ; Lee KW; Kim JH; Choi HS; Lee JS; Bang SM
Thromb Res; 2017 Jul; 155():86-91. PubMed ID: 28525829
[TBL] [Abstract][Full Text] [Related]
36. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
[TBL] [Abstract][Full Text] [Related]
38. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.
Moulis G; Lapeyre-Mestre M; Mahévas M; Montastruc JL; Sailler L
Am J Hematol; 2015 Apr; 90(4):301-5. PubMed ID: 25557586
[TBL] [Abstract][Full Text] [Related]
39. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany.
Sutor AH; Harms A; Kaufmehl K
Semin Thromb Hemost; 2001 Jun; 27(3):253-67. PubMed ID: 11446659
[TBL] [Abstract][Full Text] [Related]
40. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients.
Neylon AJ; Saunders PW; Howard MR; Proctor SJ; Taylor PR;
Br J Haematol; 2003 Sep; 122(6):966-74. PubMed ID: 12956768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
